A detailed history of Pdt Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pdt Partners, LLC holds 1,000 shares of AMGN stock, worth $283,610. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,004 0.4%
Holding current value
$283,610
Previous $313,000 2.88%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $1,237 - $1,349
-4 Reduced 0.4%
1,000 $322,000
Q2 2024

Aug 15, 2024

BUY
$262.75 - $319.31 $263,801 - $320,587
1,004 New
1,004 $313,000
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $613,680 - $692,304
2,400 New
2,400 $691,000
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $7.51 Million - $8.39 Million
-44,469 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $7.44 Million - $8.49 Million
44,469
44,469 $8.29 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.